PLAT and pulmonary embolism: In addition, some authors have suggested the use of recombinant tissue plasminogen activator (r-tPA) in severely hypoxaemic patients not responding to therapeutic dose anticoagulation as pulmonary vasculature microthrombi and pulmonary embolism are often the causative factors [32].